Literature DB >> 17940881

Relative expression of mRNAS coding for glutaminase isoforms in CNS tissues and CNS tumors.

Monika Szeliga1, Ewa Matyja, Marta Obara, Wiesława Grajkowska, Tomasz Czernicki, Jan Albrecht.   

Abstract

Glutaminase (GA) in mammalian tissues occurs in three isoforms: LGA (liver-type), KGA (kidney-type) and GAC (a KGA variant). Our previous study showed that human malignant gliomas (WHO grades III and IV) lack expression of LGA mRNA but are enriched in GAC mRNA relative to KGA mRNA. Here we analyzed the expression of mRNAs coding for the three isoforms in the biopsy material derived from other central nervous system tumors of WHO grades I-III. Non-neoplastic resective epileptic surgery samples served as control, as did cultured rat astrocytes and neurons. The GAC mRNA/KGA mRNA expression ratio was as a rule higher in the neoplastic than in control tissues, irrespective of the cell type dominating in the tumor or tumor malignancy. LGA mRNA expression was relatively very low in cultured astrocytes, and very low to absent in astrocytoma pilocyticum, ependymoma and subependymal giant cell astrocytoma (SEGA), tumors of astrocytic origin. LGA mRNA expression was almost as high as that of KGA and GAC mRNA in cultured neurons and epileptic surgery samples which were enriched in neurons. LGA mRNA was also relatively high in ganglioglioma which contains a discernable proportion of neuronal cells, and in oligodendroglioma. The results show that low expression of LGA mRNA is a feature common to normal astrocytes and astroglia-derived tumor cells or ependymomas and can be considered as a cell-type, rather than a malignancy marker.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940881     DOI: 10.1007/s11064-007-9507-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

1.  Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase.

Authors:  P M Gómez-Fabre; J C Aledo; A Del Castillo-Olivares; F J Alonso; I Núñez De Castro; J A Campos; J Márquez
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation.

Authors:  M Martin; B Beauvoit; P J Voisin; P Canioni; B Guérin; M Rigoulet
Journal:  J Bioenerg Biomembr       Date:  1998-12       Impact factor: 2.945

3.  Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing.

Authors:  K M Elgadi; R A Meguid; M Qian; W W Souba; S F Abcouwer
Journal:  Physiol Genomics       Date:  1999-08-31       Impact factor: 3.107

4.  Postembedding immunogold labelling reveals subcellular localization and pathway-specific enrichment of phosphate activated glutaminase in rat cerebellum.

Authors:  J H Laake; Y Takumi; J Eidet; I A Torgner; B Roberg; E Kvamme; O P Ottersen
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 5.  Relevance of glutamine metabolism to tumor cell growth.

Authors:  M A Medina; F Sánchez-Jiménez; J Márquez; A Rodríguez Quesada; I Núñez de Castro
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

6.  Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas.

Authors:  Monika Szeliga; Marta Sidoryk; Ewa Matyja; Paweł Kowalczyk; Jan Albrecht
Journal:  Neurosci Lett       Date:  2005-02-21       Impact factor: 3.046

7.  Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

Authors:  C Lobo; M A Ruiz-Bellido; J C Aledo; J Márquez; I Núñez De Castro; F J Alonso
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

8.  Complexity and species variation of the kidney-type glutaminase gene.

Authors:  L David Porter; Hend Ibrahim; Lynn Taylor; Norman P Curthoys
Journal:  Physiol Genomics       Date:  2002-04-16       Impact factor: 3.107

Review 9.  Glutaminase: a multifaceted protein not only involved in generating glutamate.

Authors:  Javier Márquez; Amada R López de la Oliva; José M Matés; Juan A Segura; Francisco J Alonso
Journal:  Neurochem Int       Date:  2006-03-03       Impact factor: 3.921

10.  Glutaminase in neurons and astrocytes cultured from mouse brain: kinetic properties and effects of phosphate, glutamate, and ammonia.

Authors:  S Hogstad; G Svenneby; I A Torgner; E Kvamme; L Hertz; A Schousboe
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

View more
  23 in total

Review 1.  Glutamate and the biology of gliomas.

Authors:  John de Groot; Harald Sontheimer
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

2.  Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders.

Authors:  Yunlong Huang; Lixia Zhao; Beibei Jia; Li Wu; Yuju Li; Norman Curthoys; Jialin C Zheng
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 3.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

Review 4.  Mammalian glutaminase isozymes in brain.

Authors:  Javier Márquez; Carolina Cardona; José A Campos-Sandoval; Ana Peñalver; Marta Tosina; José M Matés; Mercedes Martín-Rufián
Journal:  Metab Brain Dis       Date:  2012-11-14       Impact factor: 3.584

Review 5.  Glutamate and Brain Glutaminases in Drug Addiction.

Authors:  Javier Márquez; José A Campos-Sandoval; Ana Peñalver; José M Matés; Juan A Segura; Eduardo Blanco; Francisco J Alonso; Fernando Rodríguez de Fonseca
Journal:  Neurochem Res       Date:  2016-12-23       Impact factor: 3.996

6.  Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth.

Authors:  A Pieter J van den Heuvel; Junping Jing; Richard F Wooster; Kurtis E Bachman
Journal:  Cancer Biol Ther       Date:  2012-08-15       Impact factor: 4.742

7.  THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism.

Authors:  Zhu-Jun Cheng; Du-Ling Miao; Qiu-Yun Su; Xiao-Li Tang; Xiao-Lei Wang; Li-Bin Deng; Hui-Dong Shi; Hong-Bo Xin
Journal:  Acta Pharmacol Sin       Date:  2018-11-16       Impact factor: 6.150

Review 8.  Glutamine Addiction In Gliomas.

Authors:  Javier Márquez; Francisco J Alonso; José M Matés; Juan A Segura; Mercedes Martín-Rufián; José A Campos-Sandoval
Journal:  Neurochem Res       Date:  2017-03-09       Impact factor: 3.996

9.  In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage.

Authors:  Nathan Erdmann; Changhai Tian; Yunlong Huang; Jianxing Zhao; Shelley Herek; Norman Curthoys; Jialin Zheng
Journal:  J Neurochem       Date:  2009-02-13       Impact factor: 5.372

10.  Kinetics of a novel isoform of phosphate activated glutaminase (PAG) in SH-SY5Y neuroblastoma cells.

Authors:  B A Roberg; I Aa Torgner; E Kvamme
Journal:  Neurochem Res       Date:  2009-10-27       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.